Meeder Asset Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Meeder Asset Management’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,878	Closed	-$15K	–	2697
2020 Q1	$15K	Buy	5,878 +3,846	+189%	+$6.31K	﹤0.01%	1369
2019 Q4	$2K	Buy	2,032 +237	+13%	+$379	﹤0.01%	2090
2019 Q3	$3K	Buy	+1,795	New	+$5.46K	﹤0.01%	1923
2018 Q4	–	Sell	-7	Closed	–	–	1868
2018 Q3	$0	Buy	+7	New	+$78	﹤0.01%	1767

Meeder Asset Management's NTGN Position: Q2 2020 in Review

Meeder Asset Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 5,878 shares — an estimated $15K sold.

Meeder Asset Management first reported a position in NTGN in Q3 2018 and held it in 4 quarters. The position peaked at $15K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Meeder Asset Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Meeder Asset Management sold 5,878 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $15K.
Meeder Asset Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
Meeder Asset Management's Neon Therapeutics, Inc. Common Stock position peaked at $15K in Q1 2020.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.